Cargando…
Pneumonia in myasthenia gravis: Microbial etiology and clinical management
INTRODUCTION: Patients with myasthenia gravis (MG) are prone to the development of pneumonia due to the long-term immunotherapies they receive and a tendency for aspiration. Pneumonia remains a risk factor for MG worsening and is the most prevalent cause of mortality in MG patients. Classification o...
Autores principales: | Su, Manqiqige, Jin, Shan, Jiao, Kexin, Yan, Chong, Song, Jie, Xi, Jianying, Zhao, Chongbo, Zhou, Zhirui, Zheng, Jianming, Luo, Sushan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780595/ https://www.ncbi.nlm.nih.gov/pubmed/36569203 http://dx.doi.org/10.3389/fcimb.2022.1016728 |
Ejemplares similares
-
Herpesvirus entry mediator on T cells as a protective factor for myasthenia gravis: A Mendelian randomization study
por: Zhong, Huahua, et al.
Publicado: (2022) -
Risk factors for pregnancy-related clinical outcome in myasthenia gravis: a systemic review and meta-analysis
por: Su, Manqiqige, et al.
Publicado: (2022) -
Increased serum IL-2, IL-4, IL-5 and IL-12p70 levels in AChR subtype generalized myasthenia gravis
por: Huan, Xiao, et al.
Publicado: (2022) -
Increased Frequency of Myeloid-Derived Suppressor Cells in Myasthenia Gravis After Immunotherapy
por: Wang, Yan, et al.
Publicado: (2022) -
A Targeted Complement Inhibitor CRIg/FH Protects Against Experimental Autoimmune Myasthenia Gravis in Rats via Immune Modulation
por: Song, Jie, et al.
Publicado: (2022)